Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Nogo-A inhibits necdin-accelerated neurite outgrowth by retaining necdin in the cytoplasm.

Liu X, Wang Y, Zhang Y, Zhu W, Xu X, Niinobe M, Yoshikawa K, Lu C, He C.

Mol Cell Neurosci. 2009 May;41(1):51-61. doi: 10.1016/j.mcn.2009.01.009. Epub 2009 Feb 6.

PMID:
19386232
2.

Up-regulation of syntaxin1 in ischemic cortex after permanent focal ischemia in rats.

Cao F, Hata R, Zhu P, Niinobe M, Sakanaka M.

Brain Res. 2009 May 26;1272:52-61. doi: 10.1016/j.brainres.2009.03.047. Epub 2009 Apr 1.

PMID:
19344701
3.

Single mage gene in the chicken genome encodes CMage, a protein with functional similarities to mammalian type II Mage proteins.

López-Sánchez N, González-Fernández Z, Niinobe M, Yoshikawa K, Frade JM.

Physiol Genomics. 2007 Jul 18;30(2):156-71. Epub 2007 Mar 20.

PMID:
17374844
4.

Overexpression of SOCS3 inhibits astrogliogenesis and promotes maintenance of neural stem cells.

Cao F, Hata R, Zhu P, Ma YJ, Tanaka J, Hanakawa Y, Hashimoto K, Niinobe M, Yoshikawa K, Sakanaka M.

J Neurochem. 2006 Jul;98(2):459-70.

5.

Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue.

Goldfine AB, Crunkhorn S, Costello M, Gami H, Landaker EJ, Niinobe M, Yoshikawa K, Lo D, Warren A, Jimenez-Chillaron J, Patti ME.

Diabetes. 2006 Mar;55(3):640-50.

6.

Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin.

Tseng YH, Butte AJ, Kokkotou E, Yechoor VK, Taniguchi CM, Kriauciunas KM, Cypess AM, Niinobe M, Yoshikawa K, Patti ME, Kahn CR.

Nat Cell Biol. 2005 Jun;7(6):601-11. Epub 2005 May 15.

PMID:
15895078
7.

Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.

Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, Wu T, Niinobe M, Yoshikawa K, Hannigan GE, Halaban R.

Cancer Res. 2004 Aug 1;64(15):5270-82.

8.

Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells.

Brunelli S, Tagliafico E, De Angelis FG, Tonlorenzi R, Baesso S, Ferrari S, Niinobe M, Yoshikawa K, Schwartz RJ, Bozzoni I, Ferrari S, Cossu G.

Circ Res. 2004 Jun 25;94(12):1571-8. Epub 2004 May 20.

PMID:
15155529
9.

Expression of the Prader-Willi gene Necdin during mouse nervous system development correlates with neuronal differentiation and p75NTR expression.

Andrieu D, Watrin F, Niinobe M, Yoshikawa K, Muscatelli F, Fernandez PA.

Gene Expr Patterns. 2003 Dec;3(6):761-5.

PMID:
14643685
10.

The p75 neurotrophin receptor interacts with multiple MAGE proteins.

Tcherpakov M, Bronfman FC, Conticello SG, Vaskovsky A, Levy Z, Niinobe M, Yoshikawa K, Arenas E, Fainzilber M.

J Biol Chem. 2002 Dec 20;277(51):49101-4. Epub 2002 Oct 31.

11.

Cellular and subcellular localization of necdin in fetal and adult mouse brain.

Niinobe M, Koyama K, Yoshikawa K.

Dev Neurosci. 2000;22(4):310-9.

PMID:
10965153
12.

The postmitotic growth suppressor necdin interacts with a calcium-binding protein (NEFA) in neuronal cytoplasm.

Taniguchi N, Taniura H, Niinobe M, Takayama C, Tominaga-Yoshino K, Ogura A, Yoshikawa K.

J Biol Chem. 2000 Oct 13;275(41):31674-81.

13.

Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells.

Azuma-Hara M, Taniura H, Uetsuki T, Niinobe M, Yoshikawa K.

Exp Cell Res. 1999 Sep 15;251(2):442-51.

PMID:
10471329
14.

Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein.

Uetsuki T, Takemoto K, Nishimura I, Okamoto M, Niinobe M, Momoi T, Miura M, Yoshikawa K.

J Neurosci. 1999 Aug 15;19(16):6955-64.

15.

Regulation of AP-2-synaptotagmin interaction by inositol high polyphosphates.

Mizutani A, Fukuda M, Niinobe M, Mikoshiba K.

Biochem Biophys Res Commun. 1997 Nov 7;240(1):128-31.

PMID:
9367896
16.

Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high-polyphosphate binding at mammalian cholinergic synapses.

Mochida S, Fukuda M, Niinobe M, Kobayashi H, Mikoshiba K.

Neuroscience. 1997 Apr;77(4):937-43.

PMID:
9130775
17.

Distinct roles of C2A and C2B domains of synaptotagmin in the regulation of exocytosis in adrenal chromaffin cells.

Ohara-Imaizumi M, Fukuda M, Niinobe M, Misonou H, Ikeda K, Murakami T, Kawasaki M, Mikoshiba K, Kumakura K.

Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):287-91.

18.

Myelin proteolipid protein (PLP), but not DM-20, is an inositol hexakisphosphate-binding protein.

Yamaguchi Y, Ikenaka K, Niinobe M, Yamada H, Mikoshiba K.

J Biol Chem. 1996 Nov 1;271(44):27838-46.

19.

Role of the C2B domain of synaptotagmin in vesicular release and recycling as determined by specific antibody injection into the squid giant synapse preterminal.

Fukuda M, Moreira JE, Lewis FM, Sugimori M, Niinobe M, Mikoshiba K, Llinás R.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10708-12.

20.

Role of the C2A domain of synaptotagmin in transmitter release as determined by specific antibody injection into the squid giant synapse preterminal.

Mikoshiba K, Fukuda M, Moreira JE, Lewis FM, Sugimori M, Niinobe M, Llinás R.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10703-7.

21.

Functional diversity of C2 domains of synaptotagmin family. Mutational analysis of inositol high polyphosphate binding domain.

Fukuda M, Kojima T, Aruga J, Niinobe M, Mikoshiba K.

J Biol Chem. 1995 Nov 3;270(44):26523-7.

22.

The inositol high-polyphosphate series blocks synaptic transmission by preventing vesicular fusion: a squid giant synapse study.

Llinás R, Sugimori M, Lang EJ, Morita M, Fukuda M, Niinobe M, Mikoshiba K.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12990-3.

23.

Synaptotagmin is an inositol polyphosphate binding protein: isolation and characterization as an Ins 1,3,4,5-P4 binding protein.

Niinobe M, Yamaguchi Y, Fukuda M, Mikoshiba K.

Biochem Biophys Res Commun. 1994 Dec 15;205(2):1036-42.

PMID:
7802629
24.

Inositol-1,3,4,5-tetrakisphosphate binding to C2B domain of IP4BP/synaptotagmin II.

Fukuda M, Aruga J, Niinobe M, Aimoto S, Mikoshiba K.

J Biol Chem. 1994 Nov 18;269(46):29206-11.

25.

A new gerbil model of hindbrain ischemia by extracranial occlusion of the bilateral vertebral arteries.

Hata R, Matsumoto M, Kitagawa K, Matsuyama T, Ohtsuki T, Tagaya M, Handa N, Niinobe M, Mikoshiba K, Nishimura T, et al.

J Neurol Sci. 1994 Jan;121(1):79-89.

PMID:
8133314
26.

Differential vulnerability in the hindbrain neurons and local cerebral blood flow during bilateral vertebral occlusion in gerbils.

Hata R, Matsumoto M, Hatakeyama T, Ohtsuki T, Handa N, Niinobe M, Mikoshiba K, Sakaki S, Nishimura T, Yanagihara T, et al.

Neuroscience. 1993 Sep;56(2):423-39.

PMID:
8247270
27.

Basic fibroblast growth factor rescues CNS neurons from cell death caused by high oxygen atmosphere in culture.

Enokido Y, Akaneya Y, Niinobe M, Mikoshiba K, Hatanaka H.

Brain Res. 1992 Dec 25;599(2):261-71.

PMID:
1291034
28.

Two types of ryanodine receptors in mouse brain: skeletal muscle type exclusively in Purkinje cells and cardiac muscle type in various neurons.

Kuwajima G, Futatsugi A, Niinobe M, Nakanishi S, Mikoshiba K.

Neuron. 1992 Dec;9(6):1133-42.

PMID:
1334420
29.

Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils.

Tagaya M, Matsumoto M, Kitagawa K, Niinobe M, Ohtsuki T, Hata R, Ogawa S, Handa N, Mikoshiba K, Kamada T.

Life Sci. 1992;51(4):253-9.

PMID:
1625516
30.

The synapsin I brain distribution in ischemia.

Kitagawa K, Matsumoto M, Sobue K, Tagaya M, Okabe T, Niinobe M, Ohtsuki T, Handa N, Kimura K, Mikoshiba K, et al.

Neuroscience. 1992;46(2):287-99.

PMID:
1542407
31.

The inositol 1,4,5-trisphosphate receptor.

Mikoshiba K, Furuichi T, Miyawaki A, Yoshikawa S, Maeda N, Niinobe M, Nakade S, Nakagawa T, Okano H, Aruga J.

Ciba Found Symp. 1992;164:17-29; discussion 29-35. Review.

PMID:
1327678
32.

Primary structure and functional expression of the inositol 1,4,5-trisphosphate receptor, P400.

Mikoshiba K, Furuichi T, Maeda N, Yoshikawa S, Miyawaki A, Niinobe M, Wada K.

Adv Exp Med Biol. 1991;287:83-95. Review. No abstract available.

PMID:
1662017
33.

'Ischemic tolerance' phenomenon found in the brain.

Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, et al.

Brain Res. 1990 Sep 24;528(1):21-4.

PMID:
2245337
34.

Characterization of binding sites for spider toxin, [3H]NSTX-3, in the rat brain.

Ino H, Nakade S, Niinobe M, Ikenaka K, Teshima T, Wakamiya T, Matsumoto T, Shiba T, Kawai N, Mikoshiba K.

Neurosci Res. 1990 Apr;8(1):29-39.

PMID:
2163047
35.

Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death.

Kitagawa K, Matsumoto M, Oda T, Niinobe M, Hata R, Handa N, Fukunaga R, Isaka Y, Kimura K, Maeda H, et al.

Neuroscience. 1990;35(3):551-8.

PMID:
2199842
37.

Phosphorylation of P400 protein by cyclic AMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase II.

Yamamoto H, Maeda N, Niinobe M, Miyamoto E, Mikoshiba K.

J Neurochem. 1989 Sep;53(3):917-23.

PMID:
2547906
38.
39.

Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage--immunohistochemical investigation of dendritic damage.

Kitagawa K, Matsumoto M, Niinobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, et al.

Neuroscience. 1989;31(2):401-11.

PMID:
2797444
40.

Purification and characterization of P400 protein, a glycoprotein characteristic of Purkinje cell, from mouse cerebellum.

Maeda N, Niinobe M, Nakahira K, Mikoshiba K.

J Neurochem. 1988 Dec;51(6):1724-30.

PMID:
3141586
41.

Characterization of microtubule-associated protein 2 from mouse brain and its localization in the cerebellar cortex.

Niinobe M, Maeda N, Ino H, Mikoshiba K.

J Neurochem. 1988 Oct;51(4):1132-9.

PMID:
3418347
42.

Complete amino acid sequence of bovine colostrum low-Mr cysteine proteinase inhibitor.

Hirado M, Tsunasawa S, Sakiyama F, Niinobe M, Fujii S.

FEBS Lett. 1985 Jul 1;186(1):41-5.

43.

Detection of intermediary Clr with complete active site, using a synthetic proteinase inhibitor.

Niinobe M, Ueno Y, Hitomi Y, Fujii S.

FEBS Lett. 1984 Jul 9;172(2):159-62.

44.
45.

Isolation and immunological studies of high and low molecular weight cysteine proteinase inhibitors in bovine serum.

Hirado M, Niinobe M, Fujii S.

Biochim Biophys Acta. 1983 May 25;757(2):196-201.

PMID:
6601964
46.

Studies on esterolytic activity of alternative complement component factor B.

Ikari N, Hitomi Y, Niinobe M, Fujii S.

Biochim Biophys Acta. 1983 Jan 26;742(2):318-23. No abstract available.

PMID:
6549902
47.
48.
49.

A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate.

Hitomi Y, Kanda T, Niinobe M, Fujii S.

Clin Chim Acta. 1982 Mar 12;119(3):157-64.

PMID:
6461438
50.

Existence of two kinds of thiol protease inhibitors in rat serum.

Iwata D, Hirado M, Niinobe M, Fujii S.

Biochem Biophys Res Commun. 1982 Feb 26;104(4):1525-31. No abstract available.

PMID:
7041913

Supplemental Content

Loading ...
Support Center